| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.006 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.006 |
| mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.13 |
0.007 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.009 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.009 |
| mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
| mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |